Then their radioactivity was measured in a liquid scintillation counter after addition of 9 ml of toluene containing POPOP (0.01 g/liter) and PPO (6 g/liter).
Results and Discussion
L5178Y cells in control cultures grew logarithmically to a density of approximately 106 cells/ml.
Addition of bredinin or its aglycone markedly inhibited their growth. This indicates that both the aglycone and bredinin strongly inhibit growth of L5178Y cells.
Previously2
) it was found that above a relatively low concentrations of bredinin (10-5 M), a certain concentration of guanylic acid (GMP) could reverse the effect of bredinin, but that at higher concentrations of bredinin GMP could not reverse the effect of bredinin, completely.
And when the concentration of bredinin was 5 x 15-5 M or more, even in the presence of GMP, bredinin caused loss of growth rate. However, Fig. 2 shows that the cytotoxicities of both the aglycone and bredinin were well reversed by GMP, and that both agents caused loss of growth rate. The dose-response curves for the two agents coincided well.
The effects of various nucleotides, nucleosides and bases on growth depression by these agents were next examined. The results showed that GMP at a concentration of 4 x 10-5 M considerably reduced the inhibitions of growth by both the aglycone and bredinin, and that guanosine and guanine also reduced their growth inhibitory effects. Fig. 3 shows the effects These results suggest that not all the aglycone is necessarily converted to bredinin and the difference in the effects of the two agents may depend on the rate of conversion of the aglycone to bredinin. However, evidence that much of the aglycone is converted to bredinin is reported later in this paper (Fig. 9) . Further studies on this problem will be reported in the near future. Thus no difference was detected between the effects of bredinin and the aglycone. Fig. 8 shows that the inhibition of nucleic acid synthesis by these agents was also reversed by GMP. Even with a concentration of bredinin or the aglycone of 6 x 10-5 M, at which GMP did not prevent reduction in the viability, GMP completely reversed the inhibition of nucleic acid synthesis by these agents. This particularly interesting finding was confirmed in other studies, such as experiments on chromosome abnormalities. These studies will be reported in the near future.
Direct evidence for conversion of the aglycone to bredinin was obtained as follows. Bredinin has strong antifungal activity (MIC, 4 pa/ml) on Candida albicans, while the aglycone has hardly any (MIC, 1,0001ig/ml or more). Therefore, if orally administered aglycone is converted to bredinin in rats, antifungal activity should be detected in the serum. Antifungal activity was determined by in vitro bioassay. As shown in Fig. 9 after oral administration of the aglycone antifungal activity increased gradually in the serum, reaching a maximum in 4 hours. On administration of adenine with the aglycone the antifungal activity was less than that on administration of the aglycone only (Fig. 9) . We also obtained bredinin-like, crystalline material from the urine of the rats after oral administration of the aglycone. The purified material was confirmed to be bredinin from its mobility on thin-layer chromatography, and IR-, NMR-and UV-spectra. These results indicate that significant amounts of the aglycone are converted to bredinin in rats. Fig. 9 . Conversion of the aglycone to bredinirr in rats, and effect of adenine on the coversion, The aglycone (500 mg/kg) was orally admini. stered to a rat (Wistar strain, 8). Then serum specimens were collected at intervals, and the antifungal activity of the serum was determined. When added, adenine was administered simul. taneously.
O the oglycone(500mg/kg) c the aglycone (500mg/kg)with adenine (100mg/kg)
• the aglycone(500mg/kg)with adenine (200mg/kg) 
